CSBR Relative Valuation - Champions Oncology Inc

Watchlist Manager

Watchlist

Price: 8.1 USD -8.06%

Market Cap: 112m USD

Section:

Relative Value

The Relative Value of one CSBR stock under the Base Case scenario is hidden USD. Compared to the current market price of 8.1 USD, Champions Oncology Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

CSBR Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

1.9

P/S

vs History	46
vs Industry	61

Median 5Y

Industry

Forward

1.9

More Details

17.3

P/E

vs History	36
vs Industry

Median 5Y

-7.8

Industry

31.4

Forward

26.2

More Details

Negative

P/OCF

vs History
vs Industry	35

Median 5Y

7.5

Industry

19.5

More Details

Negative

P/FCFE

vs History
vs Industry	14

Median 5Y

-15.7

Industry

33.5

More Details

20.3

P/B

vs History	20
vs Industry	100

Median 5Y

Industry

2.7

More Details

1.8

EV/S

vs History	42
vs Industry	57

Median 5Y

1.9

Industry

3.8

Forward

1.9

More Details

3.6

EV/GP

vs History	42
vs Industry	58

Median 5Y

3.7

Industry

8.4

More Details

13.5

EV/EBITDA

vs History	46
vs Industry	3

Median 5Y

Industry

17.5

Forward

17.8

More Details

17.2

EV/EBIT

vs History	36
vs Industry

Median 5Y

-7.4

Industry

23.6

Forward

31.8

More Details

Negative

EV/OCF

vs History
vs Industry	38

Median 5Y

6.2

Industry

18.1

More Details

Negative

EV/FCFF

vs History
vs Industry	15

Median 5Y

-11.1

Industry

23.5

More Details

4.8

EV/IC

vs History	38
vs Industry	11

Median 5Y

4.7

Industry

2.4

More Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Champions Oncology Inc NASDAQ:CSBR	111m USD	1.9	17.3	13.5	17.2
US	P	PerkinElmer Inc LSE:0KHE	1.1T USD	402.8	3 892.4	1 364.6	2 783.4
US		Thermo Fisher Scientific Inc NYSE:TMO	164.2B USD	3.8	25.2	17.5	24.2
US		Danaher Corp NYSE:DHR	146.6B USD	6.2	38.9	21.4	31.1
KR		Samsung Biologics Co Ltd KRX:207940	71.2T KRW	14.5	55.6	32.3	44.9
CH		Lonza Group AG SIX:LONN	39.4B CHF	6	62	22.7	35.4
US		Agilent Technologies Inc NYSE:A	35B USD	5.3	30	20.3	23.9
CN		WuXi AppTec Co Ltd SSE:603259	222.8B CNY	5.4	20	19.3	19.3
US		IQVIA Holdings Inc NYSE:IQV	28.3B USD	1.8	21.2	11.7	17.4
US		Mettler-Toledo International Inc NYSE:MTD	25.4B USD	6.6	30	22.2	24.7
FR		Sartorius Stedim Biotech SA PAR:DIM	19.8B EUR	6.9	97	30.9	54.6

				Revenue Growth	P/S to Growth
US		Champions Oncology Inc NASDAQ:CSBR	Average P/S: 41.9 1.9	18%	0.1
US	P	PerkinElmer Inc LSE:0KHE	402.8	6%	67.1
US		Thermo Fisher Scientific Inc NYSE:TMO	3.8	5%	0.8
US		Danaher Corp NYSE:DHR	6.2	6%	1
KR		Samsung Biologics Co Ltd KRX:207940	14.5	18%	0.8
CH		Lonza Group AG SIX:LONN	6	14%	0.4
US		Agilent Technologies Inc NYSE:A	5.3	6%	0.9
CN		WuXi AppTec Co Ltd SSE:603259	5.4	12%	0.5
US		IQVIA Holdings Inc NYSE:IQV	1.8	5%	0.4
US		Mettler-Toledo International Inc NYSE:MTD	6.6	4%	1.7
FR		Sartorius Stedim Biotech SA PAR:DIM	6.9	11%	0.6

				Earnings Growth	PEG
US		Champions Oncology Inc NASDAQ:CSBR	Average P/E: 390 17.3	N/A	N/A
US	P	PerkinElmer Inc LSE:0KHE	3 892.4	41%	94.9
US		Thermo Fisher Scientific Inc NYSE:TMO	25.2	18%	1.4
US		Danaher Corp NYSE:DHR	38.9	21%	1.9
KR		Samsung Biologics Co Ltd KRX:207940	55.6	20%	2.8
CH		Lonza Group AG SIX:LONN	62	38%	1.6
US		Agilent Technologies Inc NYSE:A	30	15%	2
CN		WuXi AppTec Co Ltd SSE:603259	20	16%	1.2
US		IQVIA Holdings Inc NYSE:IQV	21.2	22%	1
US		Mettler-Toledo International Inc NYSE:MTD	30	8%	3.7
FR		Sartorius Stedim Biotech SA PAR:DIM	97	56%	1.7

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

	Champions Oncology Inc NASDAQ:CSBR	8.1 USD -8.06%
	Red Rock Resorts Inc NASDAQ:RRR	56.13 USD -2.08%
	Lithia Motors Inc NYSE:LAD	350.51 USD -1.71%
	Vulcan Energy Resources Ltd ASX:VUL	3.48 AUD -13%
M	Milestone Scientific Inc AMEX:MLSS	0.67 USD -0.03%

	Johnson & Johnson NYSE:JNJ	156.9 USD -0.5%
	Berkshire Hathaway Inc NYSE:BRK.A	712 842 USD -0.6%
	Bank of America Corp NYSE:BAC	46.73 USD -0.51%
	Mastercard Inc NYSE:MA	550.18 USD -2.37%
	UnitedHealth Group Inc NYSE:UNH	304.1 USD 1.53%
	Exxon Mobil Corp NYSE:XOM	115.43 USD 0.44%

	Franklin Covey Co NYSE:FC	19.87 USD -4.7%
	Mohawk Industries Inc NYSE:MHK	112.53 USD -1.14%
	Ardmore Shipping Corp NYSE:ASC	10.48 USD 1.16%
	ASGN Inc NYSE:ASGN	48.62 USD -3.76%
	Skyworks Solutions Inc NASDAQ:SWKS	75.42 USD -2.93%
	Weatherford International PLC NASDAQ:WFRD	58.15 USD 1.57%

	Johnson & Johnson NYSE:JNJ	156.9 USD -0.5%
	Bank of America Corp NYSE:BAC	46.73 USD -0.51%
	Mastercard Inc NYSE:MA	550.18 USD -2.37%
	Salesforce Inc NYSE:CRM	258.07 USD -2.24%
	Abbvie Inc NYSE:ABBV	192.45 USD -1.31%
	Home Depot Inc NYSE:HD	370.07 USD -0.87%

Champions Oncology Inc
NASDAQ:CSBR

Relative Value

Valuation Multiples

Multiples Across Competitors

CSBR Competitors Multiples
Champions Oncology Inc Competitors

See Also

Company

Help

Tools

Stocks

				EBITDA Growth	EV/EBITDA to Growth
US		Champions Oncology Inc NASDAQ:CSBR	Average EV/EBITDA: 143.3 13.5	N/A	N/A
US	P	PerkinElmer Inc LSE:0KHE	1 364.6	7%	194.9
US		Thermo Fisher Scientific Inc NYSE:TMO	17.5	6%	2.9
US		Danaher Corp NYSE:DHR	21.4	7%	3.1
KR		Samsung Biologics Co Ltd KRX:207940	32.3	17%	1.9
CH		Lonza Group AG SIX:LONN	22.7	18%	1.3
US		Agilent Technologies Inc NYSE:A	20.3	10%	2
CN		WuXi AppTec Co Ltd SSE:603259	19.3	24%	0.8
US		IQVIA Holdings Inc NYSE:IQV	11.7	9%	1.3
US		Mettler-Toledo International Inc NYSE:MTD	22.2	4%	5.6
FR		Sartorius Stedim Biotech SA PAR:DIM	30.9	20%	1.5

				EBIT Growth	EV/EBIT to Growth
US		Champions Oncology Inc NASDAQ:CSBR	Average EV/EBIT: 279.6 17.2	N/A	N/A
US	P	PerkinElmer Inc LSE:0KHE	2 783.4	32%	87
US		Thermo Fisher Scientific Inc NYSE:TMO	24.2	20%	1.2
US		Danaher Corp NYSE:DHR	31.1	17%	1.8
KR		Samsung Biologics Co Ltd KRX:207940	44.9	22%	2
CH		Lonza Group AG SIX:LONN	35.4	22%	1.6
US		Agilent Technologies Inc NYSE:A	23.9	15%	1.6
CN		WuXi AppTec Co Ltd SSE:603259	19.3	16%	1.2
US		IQVIA Holdings Inc NYSE:IQV	17.4	15%	1.2
US		Mettler-Toledo International Inc NYSE:MTD	24.7	6%	4.1
FR		Sartorius Stedim Biotech SA PAR:DIM	54.6	31%	1.8

	Monolithic Power Systems Inc NASDAQ:MPWR	736.06 USD -0.59%
	NVIDIA Corp NASDAQ:NVDA	164.92 USD 0.5%
	Pro Medicus Ltd ASX:PME	317.34 AUD -0.11%
P	Plover Bay Technologies Ltd HKEX:1523	6.15 HKD 0.65%
S	SciClone Pharmaceuticals (Holdings) Ltd HKEX:6600	18.72 HKD
	Alfa Financial Software Holdings PLC LSE:ALFA	220 GBX 0.69%

	Salesforce Inc NYSE:CRM	258.07 USD -2.24%
	Accenture PLC NYSE:ACN	281.06 USD -2.53%
	ServiceNow Inc NYSE:NOW	938.78 USD -3.03%
	Spotify Technology SA NYSE:SPOT	709.15 USD -0.11%
	EOG Resources Inc NYSE:EOG	123.04 USD 1.08%
	Applied Materials Inc NASDAQ:AMAT	197.93 USD -0.05%

52 Week Range	3.79 11.7
Price Target

Champions Oncology Inc NASDAQ:CSBR

Relative Value

Valuation Multiples

Multiples Across Competitors

CSBR Competitors Multiples Champions Oncology Inc Competitors

See Also

Company

Help

Tools

Stocks

Champions Oncology Inc
NASDAQ:CSBR

CSBR Competitors Multiples
Champions Oncology Inc Competitors